TrialThoracic cancer2025

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First-Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study.

Xiaoyou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.